June, 01 2025 Sunday 08:57 Hrs
  • SENSEX :   81,451.01

  • Top commodity trading and broking companies in India-182.01( -0.22%) 30-May-2025
top-arrow-market
Sensex 81451.01 -182.01  (-0.22) 30-May-2025
Previous Day Close
81633.02
Today's High/Low
High Low
  •  
  •  
81698.21 81286.45

Company News Details

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
561.0868795
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
79.46
175531.81
EPS(TTM)
Face Value()
Div & Yield %
83.21
2
0.45
 

Divis Laboratories Ltd
Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.
May 24,2025
Divis Laboratories has entered into a long term manufacturing and supply agreement with a global pharma company.

Under this agreement, the Company will be manufacturing and supplying advanced intermediates as per the commercial terms agreed between the parties.

The Company expects meaningful revenue contribution from this long-term agreement.

Cost of capacity addition for manufacturing under this agreement is estimated to be Rs.650-750 crore, which will be funded from the capacity reservation advance proposed to be paid by the customer phase wise under this Agreement.

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.